Key Details
Price
$80.12Last Dividend
$0.30Annual ROE
16.65%Beta
0.76Events Calendar
Next earnings date:
Feb 06, 2025Recent quarterly earnings:
Oct 30, 2024Recent annual earnings:
Feb 06, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
Nov 19, 2024Next split:
N/ARecent split:
Mar 10, 2014Analyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
CTSH stock is gaining from a growing customer base, significant growth in health science and financial services, and powerful AI-based solutions.
Are you looking for ways to choose powerful stocks that can outperform the market for your investment portfolio? The Zacks Style Scores can help you with that.
Look into how Cognizant's (CTSH) income from global markets is evolving and how this affects Wall Street's forecasts and the future of the stock.
Investors looking at Business - Software Services stocks probably know about Cognizant (CTSH) and Wipro Limited (WIT). However, which of these two stocks is more appealing for value investors?
CTSH's results for the third quarter of 2024 show improvement due to a growing number of clients and strong AI-based solutions.
Cognizant Technology Solutions exceeded Wall Street's profit expectations for the third quarter on Wednesday, benefiting from a rise in demand as more companies seek the services of the IT provider.
Cognizant (CTSH) reported quarterly earnings of $1.25 per share, which is higher than the Zacks Consensus Estimate of $1.14 per share. This is an increase compared to earnings of $1.16 per share from the same period last year.
Cognizant introduced Synapse around a year ago as a worldwide initiative to help people gain the technology skills necessary for future jobs. This program aims to prepare individuals for the evolving workforce. It is based in Teaneck, New Jersey.
Cognizant and AWS have partnered to introduce generative AI solutions aimed at improving manufacturing operations for large companies in various sectors, including industrial, automotive, life sciences, and consumer goods. On October 29, 2024, Cognizant announced this strategic collaboration agreement, which will focus on providing advanced technology and cloud services. The goal is to enhance smart manufacturing capabilities for businesses worldwide.
Cognizant has announced a new partnership with Alnylam Pharmaceuticals, a top biopharmaceutical company known for its work in RNA interference (RNAi) therapies. The collaboration will use Cognizant's advanced managed services tools to improve automation and lessen operational workloads for Alnylam. This agreement was revealed on October 29, 2024, in Teaneck, New Jersey.
FAQ
- What is the primary business of Cognizant Technology Solutions?
- What is the ticker symbol for Cognizant Technology Solutions?
- Does Cognizant Technology Solutions pay dividends?
- What sector is Cognizant Technology Solutions in?
- What industry is Cognizant Technology Solutions in?
- What country is Cognizant Technology Solutions based in?
- When did Cognizant Technology Solutions go public?
- Is Cognizant Technology Solutions in the S&P 500?
- Is Cognizant Technology Solutions in the NASDAQ 100?
- Is Cognizant Technology Solutions in the Dow Jones?
- When was Cognizant Technology Solutions's last earnings report?
- When does Cognizant Technology Solutions report earnings?
- Should I buy Cognizant Technology Solutions stock now?